Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PEOPLE - Theragenics (US) makes appointment:

This article was originally published in Clinica

Executive Summary

Theragenics (Buford, Georgia), the manufacturer of TheraSeed, a device used in the treatment of localised prostate cancer, has appointed James Maclennan as CFO and treasurer. Mr Maclennan most recently served as executive vice-president and CFO of technical products and digital solutions company Lanier Worldwide. It has also promoted Bruce Smith to the position of vice-president of strategy, development and acquisitions. Mr Smith, who has served Theragenics for 15 years, most recently served as CFO - a position he held for 13 years.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT067777

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel